Lindsay Androski

President and CEO at Arbutus Biopharma · 4 reported transactions in 1 company · latest report Sep 18, 2026

Their trades


Arbutus BiopharmaABUS	Shares withheld for tax $418.4K · 82,527 shares	Sep 18, 2026
Arbutus BiopharmaABUS	Exercised options $45.9K · 10,456 shares	Sep 18, 2026
Arbutus BiopharmaABUS	Exercised options $372.5K · 116,408 shares	Sep 18, 2026
Arbutus BiopharmaABUS	Share award — · 28,000 shares	Feb 2, 2026

Shares withheld for taxArbutus Biopharma

Sep 18, 2026 · ABUS

$418.4K

Sep 18, 2026 · ABUS

$45.9K

Sep 18, 2026 · ABUS

$372.5K

Feb 2, 2026 · ABUS

28,000

4 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

President and CEO at Arbutus Biopharma · 4 reported transactions in 1 company · latest report Sep 18, 2026


Arbutus BiopharmaABUS	Shares withheld for tax $418.4K · 82,527 shares	Sep 18, 2026
Arbutus BiopharmaABUS	Exercised options $45.9K · 10,456 shares	Sep 18, 2026
Arbutus BiopharmaABUS	Exercised options $372.5K · 116,408 shares	Sep 18, 2026
Arbutus BiopharmaABUS	Share award — · 28,000 shares	Feb 2, 2026